-- Telix Pharmaceuticals（ASX：TLX）周二表示，其在研显像剂TLX250-Px有望用于诊断除透明细胞肾细胞癌（ccRCC）以外的其他肾癌。该公司援引发表在《欧洲泌尿外科杂志》（European Urology）上的一项独立分析称，该分析显示，TLX250-Px的三期临床试验数据表明，PET扫描阳性结果对恶性肿瘤具有“高度预测性”，包括非透明细胞肾细胞癌，其阳性预测值高达98%。 Telix集团首席医疗官David Cade表示：“ZIRCON研究中几乎所有ccRCC假阳性结果均已被证实为其他恶性肾癌亚型，这降低了过度治疗的风险，并进一步支持了该药物的临床应用。”
Related Articles
Asia
Market Chatter: Billionaire Pamela Wall Said to Sell AU$300 Million Codan Shares in Block Trade
Codan's (ASX:CDA) largest individual shareholder, the billionaire Pamela Wall, is said to have approved a block trade, valued at around AU$300 million, the Australian Financial Review reported Tuesday, citing anonymous people involved in the transaction.Wall will retain around AU$1.2 billion in Codan shares after the reported sell down.Canaccord Genuity is said to be working on the trade. It is understood shares were being offered at about AU$39 each, per the report.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:CDA
Asia
Great Boulder Resources Secures AU$40 Million in Two-Tranche Placement; Shares Up 19%
Great Boulder Resources (ASX:GBR) secured firm commitments to raise AU$40 million from institutional and sophisticated investors through a two-tranche placement, issuing around 470.6 million shares at AU$0.085 each, representing a discount of nearly 14% to its 10-day volume-weighted average price, according to a Tuesday filing with the Australian bourse.The first tranche is expected to raise about AU$12.4 million from 145.5 million shares, while the second tranche aims to generate around AU$27.6 million from 325.1 million shares, subject to shareholder approval, the filing said.The funds will be used to support the company's acquisition of the Peak Hill gold project from Aragon Resources, a wholly owned subsidiary of Westgold Resources (ASX:WGX), the filing added.The company's shares jumped 19% in recent Tuesday trade.
$ASX:GBR$ASX:WGX
Asia
Grab Attributable Profit Surges in Q1
Singapore-headquartered ride-hailing company Grab reported attributable profit of $136 million in the first quarter of the year from $24 million a year earlier, according to a company release on Tuesday.Basic earnings per share were $0.03 compared with EPS of $0.01 a year ago.Revenue climbed 24% year over year to $955 million from $773 million, backed by growth across the on-demand and financial services segments.
$^STI